SCHENA, Francesco Paolo
 Distribuzione geografica
Continente #
NA - Nord America 6.567
AS - Asia 2.397
EU - Europa 1.994
SA - Sud America 580
Continente sconosciuto - Info sul continente non disponibili 368
AF - Africa 106
OC - Oceania 6
AN - Antartide 1
Totale 12.019
Nazione #
US - Stati Uniti d'America 6.316
SG - Singapore 953
IT - Italia 623
CN - Cina 533
BR - Brasile 462
SE - Svezia 321
HK - Hong Kong 264
RU - Federazione Russa 245
DE - Germania 195
VN - Vietnam 172
FI - Finlandia 144
FR - Francia 123
GB - Regno Unito 123
CA - Canada 120
BD - Bangladesh 108
IN - India 88
UA - Ucraina 42
AR - Argentina 36
ID - Indonesia 36
BE - Belgio 35
MX - Messico 33
TR - Turchia 33
IQ - Iraq 30
JP - Giappone 28
NL - Olanda 28
ZA - Sudafrica 26
PL - Polonia 25
CI - Costa d'Avorio 24
CO - Colombia 21
EC - Ecuador 21
SA - Arabia Saudita 21
GT - Guatemala 16
LT - Lituania 16
PH - Filippine 16
SV - El Salvador 15
UZ - Uzbekistan 15
CR - Costa Rica 14
AT - Austria 13
MA - Marocco 13
PK - Pakistan 12
ES - Italia 11
IE - Irlanda 11
IL - Israele 11
CZ - Repubblica Ceca 10
MY - Malesia 10
TN - Tunisia 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
NI - Nicaragua 9
JM - Giamaica 8
CW - ???statistics.table.value.countryCode.CW??? 7
IR - Iran 7
JO - Giordania 7
KE - Kenya 7
PY - Paraguay 7
TT - Trinidad e Tobago 7
AU - Australia 6
BO - Bolivia 6
CL - Cile 6
EG - Egitto 6
HN - Honduras 6
LB - Libano 6
ET - Etiopia 5
GP - Guadalupe 5
KW - Kuwait 5
PR - Porto Rico 5
TH - Thailandia 5
DZ - Algeria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PE - Perù 4
AO - Angola 3
AZ - Azerbaigian 3
BB - Barbados 3
DO - Repubblica Dominicana 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BS - Bahamas 2
CH - Svizzera 2
EE - Estonia 2
EU - Europa 2
GR - Grecia 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
SC - Seychelles 2
SI - Slovenia 2
SR - Suriname 2
AL - Albania 1
AQ - Antartide 1
BF - Burkina Faso 1
Totale 11.640
Città #
Ashburn 814
Fairfield 565
Singapore 499
San Jose 474
Chandler 407
Woodbridge 328
Houston 268
Hong Kong 262
Nyköping 259
Ann Arbor 255
Cambridge 232
Seattle 217
Milan 209
Beijing 174
Wilmington 171
New York 152
Council Bluffs 135
Los Angeles 107
Helsinki 104
Santa Clara 82
Dallas 80
Dearborn 76
Jacksonville 76
Lawrence 75
Roxbury 75
Lauterbourg 74
Nanjing 73
Munich 67
Bari 62
Rome 60
Ho Chi Minh City 59
São Paulo 54
Des Moines 47
Brooklyn 39
Inglewood 39
Phoenix 39
Columbus 36
Hanoi 36
Brussels 34
Buffalo 34
Montreal 34
Boardman 33
Toronto 33
Chicago 30
San Diego 30
Atlanta 25
Abidjan 24
Warsaw 24
Jakarta 22
Tokyo 22
Shenyang 21
Frankfurt am Main 20
London 19
Orem 19
Turku 18
Amsterdam 17
Stockholm 17
Dong Ket 16
Falkenstein 16
Nanchang 16
Hebei 15
Jiaxing 15
Johannesburg 15
San Francisco 15
Turin 15
Guangzhou 14
Guatemala City 14
Boston 13
Naples 13
Nuremberg 13
Princeton 13
San Salvador 13
Tashkent 13
The Dalles 13
Chennai 12
Hefei 12
Nashville 12
Paris 12
Rio de Janeiro 12
San José 12
Denver 11
Mexico City 11
North Bergen 11
Curitiba 10
Dhaka 10
Dublin 10
Guayaquil 10
Redwood City 10
Ankara 9
Baghdad 9
Bologna 9
Brasília 9
Figino 9
Ribeirão Preto 9
Biên Hòa 8
Da Nang 8
Florence 8
Kunming 8
Leawood 8
Managua 8
Totale 7.756
Nome #
Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy 237
Inhibin-A and Decorin Secreted by Human Adult Renal Stem/Progenitor Cells Through the TLR2 Engagement Induce Renal Tubular Cell Regeneration 226
Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients 217
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy 214
A transcriptomic study of Hereditary Angioedema attacks 201
ABNORMAL METHYLATED DNA REGIONS INDICATE AN ATYPICAL RESPONSE OF THE CD4+ T CELLS IN IGA NEPHROPATHY PATIENTS 192
Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression 181
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 180
Cultivar classification of Apulian olive oils: Use of artificial neural networks for comparing NMR, NIR and merceological data 173
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 168
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis 167
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection 166
Clinical Application of Human Urinary Extracellular Vesicles in Kidney and Urologic Diseases 158
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 157
ALTERED MONOCYTE GENE EXPRESSION AND EXPANSION OF CD14 (+) CD16 (+) CELL SUBSET IN IgA NEPHROPATHY PATIENTS 155
Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy 151
Endothelial-to-Mesenchymal Transition (EndMT) in Swine Renal Ischemia Reperfusion (I/R) Injury Is Mediated by Complement and AKT Pathway 148
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 148
ALPHA-SMOOTH MUSCLE ACTIN (ALPHA-SMA) AND PLATELET-DERIVED GROWTH-FACTOR-BETA RECEPTOR (PDGF-BETA-R) EXPRESSION IN HUMAN-IGA NEPHROPATHY (IGAN) - A TUBULOINTERSTITIAL CORRELATION 148
A kinetic test for the assay of the C1 esterase-inhibitor 147
Activation of NADPH oxidase and coagulation cascade in renal ischemia-reperfusion (I/R) 146
AQP5: Renal Aquaporins Family Got a New Member 145
Complement-mediated acute induction of endothelial-to-mesenchymal transition (EndMT) in a swine model of renal ischemia/reperfusion (I/R) injury 145
MP065 ABERRANT METHYLATED DNA REGIONS LEAD TO LOW ACTIVATION OF CD4+ T CELLS WITH A CONSEQUENT IMBALANCE OF THE TH1/TH2 POLARIZATION IN IGA NEPHROPATHY PATIENTS 138
AKT activation may represent the molecular link between rapamycin (RAPA) treatment and insulin-resistance in renal transplant recipients. 137
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 135
Micropatterning control of tubular commitment in human adult renal stem cells 135
Immunosuppressive agents for treating IgA nephropathy 135
Activated Factor X Induces Peripheral Blood Mononuclear Cells Activation During Hemodialysis 134
ADULT RENAL STEM/PROGENITOR CELLS REPAIR ACUTE RENAL TUBULAR CELL INJURY BY MEANS OF SPECIFIC TLR2-DRIVEN PARACRINE FACTORS 134
Potential Reparative Role of Resident Adult Renal Stem/Progenitor Cells in Acute Kidney Injury 131
Coagulation activation induces increased NADPH-dependent reactive oxygen species (ROS) generation in haemodialysis (HD) 131
AKI and stem cells 129
COVID-19 and kidney transplantation: an Italian Survey and Consensus 126
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy 125
ISCHEMIA AND ISCHEMIA-REPERFUSION (I/R) INDUCE GLOMERULAR AND TUBULAR AKT AND NIK ACTIVATION IN HUMAN (H) AND PIG (P) KIDNEYS 124
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: Role of NF-κB and Lyn 123
Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy 120
A COMBINED MIRNA BIOMARKER FOR NON-INVASIVE DIAGNOSIS OF IDIOPATHIC IGA NEPHROPATHY: AN INTERNATIONAL MULTICENTRE STUDY (NIDIGAN STUDY) 118
RENAL EXPRESSION OF MONOCYTE CHEMOTATIC PROTEIN-1 (MPC-1) AND EPIDERMAL GROW FACTOR (EGF) IN CHILDREN WITH OBDTRUCTIVE HYDRONEPHROSIS 117
A bioartificial renal tubule device embedding human renal stem/progenitor cells 117
MicroRNAs in glomerular diseases from pathophysiology to potential treatment target 116
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 115
IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection 114
Iga Nephropathy and urinary proteomics 113
Omics studies for comprehensive understanding of immunoglobulin A nephropathy: State-of-the-art and future directions 113
Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation 112
MicroRNAs in Kidney Diseases 111
IDENTIFICATION OF QUANTITATIVE TRAIT LOCI FOR DEGLYCOSYLATED IGA1 SERUM LEVELS IN FAMILIAL IGA NEPHROPATHY 111
NMR-based metabolomic study of Apulian Coratina extra virgin olive oil extracted with a combined ultrasound and thermal conditioning process in an industrial setting 111
null 108
Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment 107
Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients 107
Multiple rare genetic variants co‐segregating with familial IgA nephropathy all act within a single immune‐related network 107
An end stage kidney disease predictor based on an artificial neural networks ensemble 106
A proton nuclear magnetic resonance-based metabolomic approach in IgA nephropathy urinary profiles 104
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 103
null 101
BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN ADULT RENAL PROGENITOR CELLS THROUGH Nox4 ACTIVATION 101
MicroRNAs in kidney diseases: New promising biomarkers for diagnosis and monitoring 100
ALTERED ANTIGEN HANDLING AND INVOLVEMENT OF THE CX3CR1-FKN AXIS IN PROMOTING HEMATURIA IN IGA NEPHROPATHY PATIENTS 99
Low coagulation-activating dialyzer reduces progression of atherosclerosis in hemodialysis modulatig serum bone morphogenetic proteins (BMPs) 98
Determination of hydroxytyrosol and tyrosol in human urine after intake of extra virgin olive oil produced with an ultrasounds-based technology 97
Is it time for personalized therapy in IgA nephropathy patients? 96
Immunosuppressive agents for treating IgA nephropathy 96
Genome-wide scan identifies a copy number variable region at 3p21.1 that influences the TLR9 expression levels in IgA nephropathy patients 95
DRG's and cost/efficacy indicators in nephrology and dialysis. Results at a hospital division 95
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells 95
null 93
Altered modulation of WNT–β-catenin and PI3K/Akt pathways in IgA nephropathy 92
RARE GENETIC VARIANTS IMPLICATED IN INNATE AND ADAPTIVE IMMUNITY CO-SEGREGATE WITH FAMILIAL IGA NEPHROPATHY 91
Patient classification and outcome prediction in IgA nephropathy 90
From-omics to personalized medicine in nephrology: Integration is the key 89
β3 adrenergic receptor as potential therapeutic target in ADPKD 89
OX40 Gene: A Potential Target for the Care of Chronic T-Cell Mediated Rejection (TCMR) 86
Erratum: Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy (Nephrology Dialysis Transplantation (2009) DOI: 10.1093/ndt/gfp356) 85
Post-hoc analysis of a tool to predict kidney failure in patients with IgA nephropathy 84
LINKAGE ANALYSIS DETECTES TWO ADDITIONAL REGIONS IN FAMILIAL IGA NEPHROPATHY 84
Pharmacogenomics: A new paradigm to personalize treatments in nephrology patients 84
Kidney and urine cell transcriptomics in IgA nephropathy and lupus nephritis: a narrative review 83
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy 83
GENOME-WIDE SCAN OF COPY NUMBER VARIATIONS (CNVS) IDENTIFIES A VARIABLE REGION AT 3P21. 1 REGULATING THE TLR9 EXPRESSION IN IGA NEPHROPATHY PATIENTS 80
C5b-9 generation and cytokine production in hemodialyzed patients 77
IgAN Genetic Risk Score in the Clinical Setting 75
Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients 73
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 70
Epidemiology and ancestral difference 70
null 69
null 69
Searching for IgA nephropathy candidate genes: Genetic studies combined with high throughput innovative investigations 68
Serum Levels of miR-148b and Let-7b at Diagnosis May Have Important Impact in the Response to Treatment and Long-Term Outcome in IgA Nephropathy 68
MIR-148B UPREGULATION MODULATING CORE 1, B1, 3-GALACTOSYLTRANSFERASE 1 EXPRESSION EXPLAINS THE ABNORMAL GLYCOSYLATION PROCESS OF IGA1 IN IGA NEPHROPATHY 68
null 65
null 62
Genome-wide association studies in kidney diseases: Quo Vadis 61
The authors reply 59
Biomarkers and Precision Medicine in IgA Nephropathy 55
New directions in the pathogenesis of primary erythrocytosis in IgAN 53
null 52
null 52
Totale 11.489
Categoria #
all - tutte 50.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022510 0 0 0 0 22 61 14 31 44 78 90 170
2022/2023998 106 162 84 82 101 150 13 118 144 7 17 14
2023/2024365 33 47 12 34 31 115 4 20 13 10 9 37
2024/20251.673 44 46 116 56 71 116 181 156 53 90 257 487
2025/20264.125 562 163 205 417 491 244 408 112 496 415 176 436
2026/20271.229 118 181 318 587 25 0 0 0 0 0 0 0
Totale 12.019